Stocks › TECH

BIO-TECHNE Corp

TECH·Nasdaq·United States United States·USD
$72.67
-0.03 (-0.04%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
TECH
BIO-TECHNE Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TECHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of TECH by members of U.S. Congress · 68 on record · 12 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Common Stock Sale
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
May 6, 2026 Apr 8, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Common Stock Purchase
$1,001 - $15,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Apr 6, 2026 Mar 26, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Mar 10, 2026 Feb 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Feb 2, 2026 Jan 28, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Jan 5, 2026 Dec 5, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Jan 5, 2026 Dec 2, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Nov 4, 2025 Oct 22, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Sep 2, 2025 Aug 1, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
Jul 2, 2025 May 26, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2025 May 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2025 May 28, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
May 14, 2025 Apr 1, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA TECHBIO-TECHNE Corp · Stock Sale
$1,001 - $15,000
May 8, 2025 Apr 8, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
May 2, 2025 Apr 29, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
May 2, 2025 Apr 9, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA TECHBIO-TECHNE Corp · Stock Purchase
$1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Common Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Common Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA TECHBIO-TECHNE Corp · Common Stock Purchase
$1,001 - $15,000
Jan 8, 2025 Dec 16, 2024 Filing ↗

Whale Activity

Position changes in TECH reported for 2026-09-30 by 679 institutional filers
Increased: 171New: 83Held: 89Decreased: 216Closed: 93No prior filing: 27
  • Increased171
  • New83
  • Held89
  • Decreased216
  • Closed93
  • No prior filing27
FilerSharesValueChange
BlackRock, Inc.14.3M$1.03Bincreased
VANGUARD CAPITAL MANAGEMENT LLC10.3M$742.9Mincreased
HBK INVESTMENTS L P7.7M$560.3Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC6.3M$460.1Mdecreased
FIL Ltd6.3M$454.6Mincreased
STATE STREET CORP6.0M$438.1Mincreased
GEODE CAPITAL MANAGEMENT, LLC5.4M$393.1Mincreased
GOLDMAN SACHS GROUP INC4.1M$300.3Mdecreased
MILLENNIUM MANAGEMENT LLC4.1M$296.5Mincreased
Invesco Ltd.3.8M$273.6Mdecreased
BALYASNY ASSET MANAGEMENT L.P.3.4M$246.7Mincreased
Ruane, Cunniff & Goldfarb L.P.3.3M$242.3Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by TECH insiders, by quarter · Form 4
-50.0K-25.0K025.0K50.0K2025 Q1: -15.3K2025 Q12025 Q2: -1,2802025 Q22025 Q3: -34.1K2025 Q32025 Q4: 02025 Q42026 Q1: -1,9762026 Q12026 Q2: -6,6362026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

859 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
HIGGINS JOHN LDirector Tax withholding −5,562 $72.51 $403K Sep 28, 2026 Form 4 ↗
HIGGINS JOHN LDirector Option exercise +15.9K $0.00 $0 Sep 28, 2026 Form 4 ↗
BAUMGARTNER ROBERT VDirector Tax withholding −5,559 $72.55 $403K Sep 22, 2026 Form 4 ↗
BAUMGARTNER ROBERT VDirector Option exercise +15.9K $0.00 $0 Sep 22, 2026 Form 4 ↗
Kelderman KimChief Executive Officer · Director Tax withholding −10.8K $72.40 $783K Aug 15, 2026 Form 4 ↗
Kelderman KimChief Executive Officer · Director Option exercise +21.5K $0.00 $0 Aug 15, 2026 Form 4 ↗
Hippel JamesCFO Tax withholding −4,310 $72.40 $312K Aug 15, 2026 Form 4 ↗
Hippel JamesCFO Option exercise +9,779 $0.00 $0 Aug 15, 2026 Form 4 ↗
Geist WilliamPRESIDENT, PROTEIN SCIENCES Tax withholding −1,976 $72.40 $143K Aug 15, 2026 Form 4 ↗
Geist WilliamPRESIDENT, PROTEIN SCIENCES Option exercise +6,416 $0.00 $0 Aug 15, 2026 Form 4 ↗
Bohnen ShaneSVP - General Counsel Tax withholding −1,343 $72.40 $97K Aug 15, 2026 Form 4 ↗
Bohnen ShaneSVP - General Counsel Option exercise +4,350 $0.00 $0 Aug 15, 2026 Form 4 ↗
Crouse Steven C.President - Diag & Spatial Bi Tax withholding −1,947 $72.40 $141K Aug 15, 2026 Form 4 ↗
Crouse Steven C.President - Diag & Spatial Bi Option exercise +5,423 $0.00 $0 Aug 15, 2026 Form 4 ↗
Herr Amy E.Director Tax withholding −213 $72.40 $15K Aug 15, 2026 Form 4 ↗
Herr Amy E.Director Option exercise +589 $0.00 $0 Aug 15, 2026 Form 4 ↗
Hippel JamesCFO Tax withholding −51.0K $72.03 $3.7M Jul 29, 2026 Form 4 ↗
Hippel JamesCFO Option exercise +62.1K $47.60 $3.0M Jul 29, 2026 Form 4 ↗
Kelderman KimChief Executive Officer · Director Tax withholding −28.7K $72.07 $2.1M Jul 28, 2026 Form 4 ↗
Kelderman KimChief Executive Officer · Director Option exercise +35.0K $47.60 $1.7M Jul 28, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding TECH · SEC Form N-PORT
FundSharesValue% of fundAs of
Fidelity Contrafund5.0M$352.5M0.20%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
5.0M$351.1M0.02%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
4.1M$286.6M0.02%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF
Invesco Exchange-Traded Fund Trust
3.6M$255.9M0.27%Jul 31, 2026
SMALLCAP World Fund Inc3.6M$253.9M0.27%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
3.6M$253.4M0.13%Jun 30, 2026
Eaton Vance Atlanta Capital SMID-Cap Fund
Eaton Vance Growth Trust
2.6M$184.0M2.09%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
2.2M$152.6M0.02%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
2.0M$147.0M0.02%Aug 31, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
2.1M$146.3M0.31%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list TECH's shares (CUSIP 09073M104), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 1.1M shares0.7%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 1.1M shares0.7%
    Nov 5, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 12.8M shares8.1%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 12.8M shares8.1%
    Aug 6, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.9M shares5.0%
    May 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G · passive (13G) · 7.9M shares5.0%
    May 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming bio techne as client
$0$3K$5K$8K$10K2023 Q4: $10K20232024 Q1: $10K202420252026
  • SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2026 Q3—
    Filing ↗
  • SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2026 Q2—
    Filing ↗
  • SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2026 Q1 · AGR—
    Filing ↗
  • SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2025 Q4—
    Filing ↗
  • SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2025 Q3 · AGR—
    Filing ↗

Government Contracts

Federal awards to bio techne · USAspending
$34KAwarded · 1 contract on record
  • Department of Health and Human ServicesRECOMBINANT RAT LEPTIN PROTEIN, CF$34K
    Sep 9, 2026 · ↗

U.S. Patents

Recent USPTO applications naming BIO-TECHNE Corp

No USPTO patent applications found for BIO-TECHNE Corp.

Annual Financials

From TECH's 10-K filings · XBRL
Fiscal yearFY2026FY2025FY2024FY2023FY2022
Revenue$1.22B$1.22B$1.16B$1.14B$1.11B
Operating income$251.9M$102.3M$206.7M$298.9M$296.6M
Net incomen/a$73.4M$168.1M$285.3M$272.1M
Diluted EPS$1.16$0.46$1.05$1.76$1.66
Operating cash flow$292.1M$287.6M$299.0M$254.4M$325.3M
Cash and equivalents$264.7M$162.2M$151.8M$180.6M$172.6M
Total assets$2.59B$2.56B$2.70B$2.64B$2.29B
Shareholders' equity$2.11B$1.92B$2.07B$1.97B$1.70B

As BIO-TECHNE Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Aug 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 4-for-1Stock splitNov 30, 2022
  • 2-for-1Stock splitDec 4, 2000
  • 2-for-1Stock splitNov 18, 1997

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 8.01, 9.01Other eventsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 5.07, 7.01, 9.01Shareholder vote · Reg FD disclosureSep 23, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsSep 14, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 12, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 5.02, 9.01Material agreement · Officer / director changeJun 26, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureJun 25, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 6, 2026
    EDGAR ↗

About BIO-TECHNE Corp

From SEC EDGAR company records

OVERVIEW Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne Corporation (“Bio-Techne”, “we”, “our”, “us” or the “Company”), develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. Our broad product portfolio and application expertise enables scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. Our products aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. We manage the business in two operating segments – our Protein Sciences segmen…

Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersMINNEAPOLIS, MN
IncorporatedMN
Former namesTECHNE CORP /MN/